dalteparin has been researched along with Pleurisy in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Pleurisy: INFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doboszyńska, A | 1 |
| Koć, M | 1 |
| Koć, K | 1 |
| Swietlik, E | 1 |
| Sosnowska, E | 1 |
| Tomaszewska, I | 1 |
1 other study available for dalteparin and Pleurisy
| Article | Year |
|---|---|
Pleuritis as the first symptom of pulmonary embolism: a case report.
Topics: Anticoagulants; Chest Pain; Enoxaparin; Female; Humans; Middle Aged; Pleurisy; Pulmonary Embolism; T | 2007 |